We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

26 hedge funds and large institutions have $6.11M invested in TriSalus Life Sciences Warrant in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
$147K
Puts
–
Net Calls
+$147K
Net Calls Change
+$147K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.66M
2
PWAM
Park West Asset Management
California
+$752K
3
AC
Aristeia Capital
Connecticut
+$694K
4
LA
Linden Advisors
New York
+$440K
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$338K

Top Sellers

No sellers this quarter

TLSIW Hedge Fund Activity: Q1 2021 in Review

26 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2021, worth a combined $6.11M.

Buyers outnumbered sellers: 26 funds opened new TLSIW positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $1.66M.

  • 26 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $6.11M of TriSalus Life Sciences Warrant stock for Q1 2021.
  • 26 funds opened new TriSalus Life Sciences Warrant positions in Q1 2021 and 0 closed out, a net change of +26 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q1 2021 was BlackRock, an estimated $1.66M added.

Based on aggregated 13F filings for Q1 2021.